National and Kapodistrian University of Athens
Κίνδυνοι και επιπλοκές της λήψης τροφοβλαστικού ιστού για προγεννητικό έλεγχο κατά το πρώτο τρίμηνο της εγκυμοσύνης
Abstract
dc:descriptionOBJECTIVE: To assess clinical complications, fetal loss rates, feasibility and risk factors associated with chorionic villus sampling (CVS) during the first trimester (9+0 - 13+6 weeks) and compare pregnancy outcomes with genetic amniocentesis during the second trimester in a University tertiary referral centre. MATERIALS-METHODS: An observational cohort study of all CVS and amniocentesis procedures for singleton and twin pregnancies was conducted during the first and second trimester respectively, from 1992–2005 at the first Department of Obstetrics and Gynaecology of University of Athens, in Alexandra Hospital. Clinical follow-up was completed for every pregnancy up to the neonatal period. Regarding singleton pregnancies a total of 4277 cases of CVS, 6915 cases of amniocentesis and 1157 low risk non-intervention group were assessed. All CVS procedures were done with the transabdominal technique. During the same period 67 twin pregnancies underwent CVS during the first trimester. STATISTICAL ANALYSIS: x2 test and Fisher's exact tests were used for the assessment of qualitative parameters. Logistic regression analysis was used to analyze risk factors for fetal losses. Year of procedure, maternal age, parity, gestational age at procedure and risk factors for fetal losses were controlled for multivariate logistic regression models. Z-Tests were used to assess clinical outcomes between the study groups adjusting fetal loss rates with the background risk of the control group (nuchal translucency group). RESULTS: There were 3132 cases of CVS, 6595 cases of amniocentesis and 1152 cases of non-interventional nuchal scans performed during the study period with complete follow-up. In addition, a group of 55 CVS procedures performed on twin pregnancies during the first trimester was assessed. The overall loss rates for singleton pregnancies (spontaneous miscarriages and endometrial deaths) were 3,32% for CVS and 1,99% for amniocentesis (P<.001). Women with a history of an increased risk for chromosomal abnormality of more than 35 years and women with significant bleeding before the procedure had a significantly higher risk for fetal loss. Increased fetal losses were found in cases with an additional invasive procedure due to laboratory failure or ambiguous results, cases of confined placental mosaicism and cases where the sampling was technically difficult. The optimal gestational age for CVS was the 11⁺¹ week of pregnancy. A significant association was found between CVS performed for women of over 35 years old and severe preeclampsia. When examined by 3-4 year intervals with similar number of CVS procedures in each one, there was a statistically significant decrease in the CVS loss rate (P<0.001) over time. Although the total pregnancy loss rate after CVS over the entire study period was higher than from amniocentesis, in the second half of the study, 1998 to 2005, there was no significant difference between the two procedures (0,4% with p=0,316). A parallel significant decline of failed samplings and additional invasive procedures was observed. For twin pregnancies, where selective feticide was not carried out, pregnancy loss rate was 4,7%. Pregnancy loss rates following CVS in twin pregnancies were not statistically different from singleton pregnancies (p=0,557). CONCLUSIONS: Chorionic villus sampling has gained a growing popularity since its inception as a means of rapid prenatal diagnosis in early pregnancy. However, this method together with other invasive procedures is not without clinical risks for both the mother and the fetus. In any case the risk for fetal abnormality should be assessed against the risk of developing a complication after the procedure, including the risk of losing a normal pregnancy. The assessment of the feasibility and safety of CVS during the first trimester showed: 1. When performed in specialized, highly experienced prenatal diagnosis centers, the additional fetal loss rates between CVS and amniocentesis were not different, ranging between 0,5 and 1%. There was no increase of limb reduction defects. 2. Extra caution should be given to women of over 35 years old presenting with a history of significant vaginal bleeding due to the increased fetal loss rates observed. 3. There appears to be an association between chorionic villus sampling and severe preeclampsia, eclampsia and HELLP syndrome, particularly for women over 35 years old. Appropriate follow-up should be implemented for these women. 4. The “learning curve” of CVS appears to be substantial, requiring approximately 400 cases, underlying the paramount importance of training under close supervision from senior and experienced operators. 5. First trimester CVS in twin pregnancies should be performed only by experienced operators, taking into account the selectivity rules, and fetoplacental mapping. Fetal loss rates are comparable with those found after CVS for singleton pregnancies. However, CVS in twins require more frequently further investigation than from singletons due to uncertain results related to sampling problems and confirmation of doubtful results. These results are informative for healthcare practitioners and for patient’s counselling, hoping to provide the appropriate and up to date information regarding the risks of chorionic villus sampling during the first trimester.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Grigoriadis, T.
- Γρηγοριάδης, Θεμιστοκλής
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18324